Docetaxel

Страна: Новая Зеландия

Язык: английский

Источник: Medsafe (Medicines Safety Authority)

Активный ингредиент:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Доступна с:

REX Medical Ltd

ИНН (Международная Имя):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

дозировка:

20 mg/mL

Фармацевтическая форма:

Concentrate for infusion

состав:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Штук в упаковке:

Vial, glass, Diluent, 1.5 mL

класс:

Prescription

Тип рецепта:

Prescription

Производитель:

Cipla Ltd

Терапевтические показания :

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Обзор продуктов:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Дата Авторизация:

2006-06-23